Market access update
How to drive payer submission readiness for your late-phase products
The PRMA Healthcheck® digital assessments of late-phase pharmaceutical assets help you to bring a clear understanding of the risks and opportunities in multiple markets based on current payer requirements.
This collection of case studies from leading pharmaceutical manufacturers explains how the PRMA Healthcheck® helps organizations to:
- focus attention on the key issues that will impact outcomes of payer assessments
- determine actions to mitigate the risks of not meeting payer expectations
- identify clear responsibilities across global, regional, and affiliate teams for implementation of payer-focused activities
- accelerate successful HTA submission and payer evaluation readiness by producing high-quality payer focused evidence that is driven by informed organizational collaboration.
Drive readiness for payer submissions for your Phase 2 and 3 products